Caricamento...
TMOD-49. ANTITUMOR EFFICACY OF ANTI-PDL1 IN ACTH-SECRETING PITUITARY ADENOMAS: AN IMMUNOTHERAPEUTIC APPROACH FOR CUSHING’S DISEASE
BACKGROUND: Cushing’s disease (CD) is caused by an ACTH-secreting pituitary adenoma that causes severe patient morbidity. First-line treatment for CD is surgical adenomectomy, but 25% of these patients will recur within 5-years. Targeting immune checkpoint Program Death Ligand-1 (PDL1) has emerged a...
Salvato in:
| Pubblicato in: | Neuro Oncol |
|---|---|
| Autori principali: | , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Oxford University Press
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5692082/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.1085 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|